Global science and technology provider Danaher Corporation (NYSE: DHR – $81.08) announced results for the quarter with net earnings from continuing operations of $656.7 million, and an adjusted per share tally of $1.25. The results for the second quarter include the operations of Fortive Corporation, which was spun-off to Danaher’s shareholders on July 2nd, after the end of the second quarter. The company’s remaining business lines will focus on life sciences, diagnostics equipment, dental appliances, water quality and product-identification gear. The company’s net earnings represent a 17% increase over the comparable 2015 amount as revenues increased 16.5% year-over-year to $5.8 billion, with core revenue growth of 2.0%. DHR’s second quarter standouts were dental, which had 4% organic-sales growth, and its environmental business with a 6% gain. Operating cash flow from continuing operations of $2.1 billion was up 26% on the comparable 2015 amount. For the third quarter 2016, Danaher anticipates that adjusted earnings, excluding the Fortive businesses, is expected to be $0.80 to $0.84 per share, a few cents below Street views. Positions can continue to be held in a well-diversified conservative portfolio.